ResearcherXiamen UniversityActive in the last 2 years
Bohan Zhan
Matched on OpenAlex author ID A5100997726. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2016: 1 paper · 2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper
Papers 4
- Metabolic difference between patient-derived xenograft model of pancreatic ductal adenocarcinoma and corresponding primary tumor. Co-author DOI 10.1186/s12885-024-12193-x↗
- Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling. First author DOI 10.1186/s12885-017-3703-9↗
- Identification and causes of metabonomic difference between orthotopic and subcutaneous xenograft of pancreatic cancer. Co-author DOI 10.18632/oncotarget.18057↗
- Metabonomic alterations from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma facilitate the identification of biomarkers in serum for … First author DOI 10.1039/c6mb00381h↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xianchao Lin · 4 shared papers, 2016–2024 · strength 0.44
- Paper Metabolic difference between patient-derived xenograft model of pancreatic ductal adenocarcinoma and corresponding prim… DOI 10.1186/s12885-024-12193-x↗
- Paper Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling. DOI 10.1186/s12885-017-3703-9↗
- Paper Identification and causes of metabonomic difference between orthotopic and subcutaneous xenograft of pancreatic cancer. DOI 10.18632/oncotarget.18057↗
- Wen Shi · 4 shared papers, 2016–2024 · strength 0.44
- Paper Metabolic difference between patient-derived xenograft model of pancreatic ductal adenocarcinoma and corresponding prim… DOI 10.1186/s12885-024-12193-x↗
- Paper Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling. DOI 10.1186/s12885-017-3703-9↗
- Paper Identification and causes of metabonomic difference between orthotopic and subcutaneous xenograft of pancreatic cancer. DOI 10.18632/oncotarget.18057↗
- Heguang Huang · 4 shared papers, 2016–2024 · strength 0.44
- Paper Metabolic difference between patient-derived xenograft model of pancreatic ductal adenocarcinoma and corresponding prim… DOI 10.1186/s12885-024-12193-x↗
- Paper Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling. DOI 10.1186/s12885-017-3703-9↗
- Paper Identification and causes of metabonomic difference between orthotopic and subcutaneous xenograft of pancreatic cancer. DOI 10.18632/oncotarget.18057↗
- Jianghua Feng · 4 shared papers, 2016–2024 · strength 0.44
- Paper Metabolic difference between patient-derived xenograft model of pancreatic ductal adenocarcinoma and corresponding prim… DOI 10.1186/s12885-024-12193-x↗
- Paper Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling. DOI 10.1186/s12885-017-3703-9↗
- Paper Identification and causes of metabonomic difference between orthotopic and subcutaneous xenograft of pancreatic cancer. DOI 10.18632/oncotarget.18057↗
- Yu Pan · 1 shared paper, 2024 · strength 0.22
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.